Work

BTK inhibitor PCI-32765 targets endogenous and microenvironment-mediated B-cell receptor signaling to suppress lymphoma cell growth and is highly synergistic with Bortezmib against non-Hodgkin B-cell lymphomas

Year: 2012

Type: article

Source: Blood

DOI: 10.1182/blood.v120.21.4721.4721

Authors: Bing Xia, Xiaowu Li, Le Zhang, Qing Guo, Xin Jin, Shanqi Guo, Eduardo M. Sotomayor, Yizhuo Zhang

Institutions: Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Moffitt Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2585217794

FWCI:

Cites:

Cited by:

Related to: 10